Development of novel gemcitabine-modified miRNA mimics for pancreatic ductal adenocarcinoma

被引：0
|
作者：
Ju, Jingfang
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 02期
关键词：
D O I：
10.1158/1538-7445.PANCA2023-B076
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B076
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma: A Physiopathologic and Pharmacologic Review
    Koltai, Tomas
    Reshkin, Stephan Joel
    Carvalho, Tiago M. A.
    Di Molfetta, Daria
    Greco, Maria Raffaella
    Alfarouk, Khalid Omer
    Cardone, Rosa Angela
    CANCERS, 2022, 14 (10)
  • [22] Inflammation and development of pancreatic ductal adenocarcinoma
    Shi, Juanjuan
    Xue, Jing
    CHINESE CLINICAL ONCOLOGY, 2019, 8 (02)
  • [23] Interrelationship between miRNA and splicing factors in pancreatic ductal adenocarcinoma
    Supadmanaba, I. Gede Putu
    Mantini, Giulia
    Randazzo, Ornella
    Capula, Mjriam
    Muller, Ittai B.
    Cascioferro, Stella
    Diana, Patrizia
    Peters, Godefridus J.
    Giovannetti, Elisa
    EPIGENETICS, 2022, 17 (04) : 381 - 404
  • [24] IDENTIFICATION OF A CIRCULATING MIRNA DIAGNOSTIC SIGNATURE IN PANCREATIC DUCTAL ADENOCARCINOMA
    Yoshida, Kazuhiro
    Toden, Shusuke
    Han, Haiyong
    Tsai, Susan
    Muhammed, Murtaza
    Celinski, Scott
    Becerra, Carlos
    Nagasaka, Takeshi
    Fujiwara, Toshiyoshi
    Evans, Douglas B.
    Hoff, Danniel V.
    Goel, Ajay
    GASTROENTEROLOGY, 2017, 152 (05) : S273 - S273
  • [25] Development of gemcitabine-resistant patient-derived xenograft models of pancreatic ductal adenocarcinoma
    Miller, Aubrey L.
    Garcia, Patrick L.
    Gamblin, Tracy L.
    Vance, Rebecca B.
    Yoon, Karina J.
    CANCER DRUG RESISTANCE, 2020, 3 (03) : 572 - 585
  • [26] Development of a novel modified miR-15a mimic with enhanced therapeutic potential for treatment of pancreatic ductal adenocarcinoma
    Guo, Shixiang
    Fesler, Andrew
    Huang, Wenjie
    Wang, Yunchao
    Yang, Jiali
    Wang, Xianxing
    Hwang, Ga-Ram
    Godwin, Matthew
    Wang, Huaizhi
    Ju, Jingfang
    CANCER RESEARCH, 2019, 79 (13)
  • [27] Overcoming Microbiome-Acquired Gemcitabine Resistance in Pancreatic Ductal Adenocarcinoma
    Mendes, Ines
    Vale, Nuno
    BIOMEDICINES, 2024, 12 (01)
  • [28] The role of survivin splice variants in pancreatic ductal adenocarcinoma Gemcitabine resistance
    Kabagwira, Janviere
    Gonda, Amber
    Kwong, Mei Li
    CANCER RESEARCH, 2019, 79 (13)
  • [29] An Update on Gemcitabine-Based Chemosensitization Strategies in Pancreatic Ductal Adenocarcinoma
    Zhang, Tianpeng
    Gu, Zongting
    Ni, Ran
    Wang, Xiao
    Jiang, Qitao
    Tao, Ran
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2023, 28 (12): : 361
  • [30] Integrated stress response is critical for gemcitabine resistance in pancreatic ductal adenocarcinoma
    L R Palam
    J Gore
    K E Craven
    J L Wilson
    M Korc
    Cell Death & Disease, 2015, 6 : e1913 - e1913
12345